Series A Preferred Shares. A total of 45,429,741 authorized Series A Preferred Shares, par value of US$0.0001 (“Series A Preferred Shares”, and each a “Series A Preferred Share”), all of which are issued and outstanding. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the Amended M&A as provided by the Company Law.
Appears in 7 contracts
Samples: Preferred Share Purchase Agreement (Burning Rock Biotech LTD), Series C Preferred Share Purchase Agreement (Burning Rock Biotech LTD), Preferred Share Purchase Agreement (Burning Rock Biotech LTD)
Series A Preferred Shares. A total of 45,429,741 119,506 authorized Series A Preferred Shares, par value of US$0.0001 (“Series A Preferred Shares”, and each a “Series A Preferred Share”)per share, all of which are issued and outstanding. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the Amended M&A as provided by the Company Law.;
Appears in 2 contracts
Samples: Share Subscription Agreement (9F Inc.), Share Subscription Agreement (9F Inc.)
Series A Preferred Shares. A total of 45,429,741 119,506 authorized Series A Preferred Shares, par value of US$0.0001 (“Series A Preferred Shares”, and each a “Series A Preferred Share”)per share, all of which are issued and outstanding. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the Amended M&A as provided by the Company Law.; and
Appears in 2 contracts
Samples: Share Subscription Agreement (9F Inc.), Share Subscription Agreement (9F Inc.)
Series A Preferred Shares. A total of 45,429,741 authorized 21,460,872 Series A A+ Preferred Shares, par value of US$0.0001 (“Series A A+ Preferred Shares”, and each a “Series A A+ Preferred Share”), all of which are issued and outstanding. The rights, privileges and preferences of the Series A A+ Preferred Shares are as stated in the Amended M&A as provided by the Company Law.
Appears in 1 contract
Samples: Second Series B Preferred Share Purchase Agreement (Burning Rock Biotech LTD)
Series A Preferred Shares. A total of 45,429,741 authorized 21,460,872 Series A A+ Preferred Shares, par value of US$0.0001 (“Series A A+ Preferred Shares”, and each a “Series A A+ Preferred Share”), all 21,199,850 of which are issued and outstanding, and 261,022 of which has not been issued. The rights, privileges and preferences of the Series A A+ Preferred Shares are as stated in the Amended M&A as provided by the Company Law. d) Series B Preferred Shares. A total of 22,166,735 Series B Preferred Shares, none of which has been issued.
Appears in 1 contract
Samples: Series B Preferred Share Purchase Agreement (Burning Rock Biotech LTD)
Series A Preferred Shares. A total of 45,429,741 100,000,000 authorized Series A Preferred Shares, par value of US$0.0001 (“Series A Preferred Shares”, and each a “Series A Preferred Share”), all Shares of which 73,597,200 are issued and outstanding. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the Amended M&A as provided by Memorandum and Articles and the Company LawAncillary Agreements.
Appears in 1 contract
Samples: Series a 1 Senior Preferred Share Purchase Agreement (Nobao Renewable Energy Holdings LTD)
